Litcius/Paper detail

Safety, tolerability and efficacy of repeated intravenous infusions of KHK4083, a fully human anti-OX40 monoclonal antibody, in Japanese patients with moderate to severe atopic dermatitis

Hidemi Nakagawa, Hajime Iizuka, Osamu Nemoto, Munetake Shimabe, Yasunobu Furukawa, Natsuko Kikuta, Kenji Ootaki

2020Journal of Dermatological Science64 citationsDOI

Topics & Concepts

MedicineTolerabilityChillsEczema Area and Severity IndexAdverse effectAtopic dermatitisCmaxPharmacodynamicsImmunogenicityPharmacokineticsInternal medicineGastroenterologyAntibodyImmunologyDermatology and Skin DiseasesAsthma and respiratory diseasesPsoriasis: Treatment and Pathogenesis
Safety, tolerability and efficacy of repeated intravenous infusions of KHK4083, a fully human anti-OX40 monoclonal antibody, in Japanese patients with moderate to severe atopic dermatitis | Litcius